These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 19800368)
1. A small molecule fusion inhibitor of dengue virus. Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368 [TBL] [Abstract][Full Text] [Related]
2. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577 [TBL] [Abstract][Full Text] [Related]
3. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel dengue virus entry inhibitors via a structure-based approach. Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194 [TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716 [TBL] [Abstract][Full Text] [Related]
6. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243 [TBL] [Abstract][Full Text] [Related]
7. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS; Wu KX; Chen KC; Ng MM; Chu JJ Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M; Singh SK Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716 [TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries. Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures. Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406 [TBL] [Abstract][Full Text] [Related]
14. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion. Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281 [TBL] [Abstract][Full Text] [Related]
15. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Lee E; Weir RC; Dalgarno L Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841 [TBL] [Abstract][Full Text] [Related]
16. Structure of the dengue virus envelope protein after membrane fusion. Modis Y; Ogata S; Clements D; Harrison SC Nature; 2004 Jan; 427(6972):313-9. PubMed ID: 14737159 [TBL] [Abstract][Full Text] [Related]
17. A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. Niedermeier S; Singethan K; Rohrer SG; Matz M; Kossner M; Diederich S; Maisner A; Schmitz J; Hiltensperger G; Baumann K; Holzgrabe U; Schneider-Schaulies J J Med Chem; 2009 Jul; 52(14):4257-65. PubMed ID: 19499921 [TBL] [Abstract][Full Text] [Related]
18. Screening of small-molecule compounds as inhibitors of HCV entry. Yang JP; Zhou D; Wong-Staal F Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270 [TBL] [Abstract][Full Text] [Related]
19. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads. Gangopadhyay A; Chakraborty HJ; Datta A J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the steps involved in Dengue virus entry into host cells. Hung SL; Lee PL; Chen HW; Chen LK; Kao CL; King CC Virology; 1999 Apr; 257(1):156-67. PubMed ID: 10208929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]